Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea flag South Korea · Delayed Price · Currency is KRW
73,700
+2,000 (2.79%)
Last updated: Jun 16, 2026, 2:03 PM KST

KRX:185750 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
174,556216,236228,470219,646117,417131,813
Short-Term Investments
88,793108,44672,549143,0958,871-
Trading Asset Securities
21,87821,8211,1522,32429,57355,520
Cash & Short-Term Investments
285,226346,503302,171365,065155,861187,333
Cash Growth
0.54%14.67%-17.23%134.22%-16.80%15.74%
Accounts Receivable
259,315265,843266,742269,632248,409203,598
Other Receivables
41,70135,38931,71140,50831,33924,697
Receivables
301,016301,232298,453310,140279,749228,295
Inventory
444,339428,649353,835261,432270,081224,723
Prepaid Expenses
4,7544,0322,7612,1412,0122,127
Other Current Assets
9,82811,4034,9337,7935,91224,670
Total Current Assets
1,045,1641,091,819962,152946,572713,615667,147
Property, Plant & Equipment
481,976437,694320,780319,787310,697298,910
Long-Term Investments
121,248101,32342,03541,14444,01033,373
Other Intangible Assets
103,99490,03074,51252,06226,95320,806
Long-Term Deferred Tax Assets
31,32934,49029,66814,2136,2092,350
Long-Term Deferred Charges
16,65117,4771,131464.72--
Other Long-Term Assets
31,44027,46628,48628,18623,39924,114
Total Assets
1,831,8011,800,2981,458,7651,402,4281,124,8831,046,700
Accounts Payable
224,883212,899200,148183,939145,436129,327
Accrued Expenses
5,01112,08212,72416,32311,06010,243
Short-Term Debt
91,14791,02864,61690,95996,27074,656
Current Portion of Long-Term Debt
71,89271,8051,88090,74027,26424,681
Current Portion of Leases
3,1883,0332,9763,068911.362,755
Current Income Taxes Payable
11,00413,72613,64543,93820,21113,127
Current Unearned Revenue
28.318.6121.9620.085.465.83
Other Current Liabilities
115,369111,53272,54982,47873,05465,435
Total Current Liabilities
522,523516,124368,559511,466374,213320,230
Long-Term Debt
195,377195,196115,95330,000110,510134,246
Long-Term Leases
6,4016,6972,7274,997782.86715.88
Pension & Post-Retirement Benefits
436.411,0995,8571,02386.699,454
Other Long-Term Liabilities
78,28574,82769,29139,30818,00216,244
Total Liabilities
803,021793,943562,387586,793503,594480,890
Common Stock
34,50734,50732,93631,42129,97028,565
Additional Paid-In Capital
268,163268,164261,969263,484257,685264,617
Retained Earnings
746,964739,646671,437577,002376,371302,107
Treasury Stock
-65,920-65,920-64,151-48,143-34,666-22,435
Comprehensive Income & Other
42,58027,358-8,222-8,070-6,967-6,843
Total Common Equity
1,026,2941,003,755893,969815,694622,393566,010
Minority Interest
2,4862,6012,409-59.33-1,104-200.34
Shareholders' Equity
1,028,7801,006,356896,378815,635621,289565,810
Total Liabilities & Equity
1,831,8011,800,2981,458,7651,402,4281,124,8831,046,700
Total Debt
368,005367,758188,152219,764235,738237,054
Net Cash (Debt)
-82,778-21,255114,018145,301-79,877-49,721
Net Cash Growth
---21.53%---
Net Cash Per Share
-6218.34-1596.608607.8210399.38-5933.68-3628.24
Filing Date Shares Outstanding
13.1813.1812.5712.7312.813.01
Total Common Shares Outstanding
13.1813.1813.213.3613.4413.66
Working Capital
522,641575,695593,594435,106339,402346,917
Book Value Per Share
77890.7876180.1367747.6161048.8946314.7941433.07
Tangible Book Value
922,301913,724819,456763,632595,440545,204
Tangible Book Value Per Share
69998.1669347.2862100.8457152.3944309.1039910.06
Land
267,232214,233112,346111,145116,028108,235
Buildings
209,942209,317208,896206,005191,667183,170
Machinery
348,728345,173331,375292,292274,583252,066
Construction In Progress
31,14735,4017,38321,71619,94619,901